Stockholm is growing and we want a smart city with knowledge-intensive industry that is sustainable. In a panel discussion during Science Week on February 1, we discuss how innovative neutral arenas are central to the development of the smart and knowledge-intensive city.
In January 2022, the Flemingsberg Science Foundation adopted its new strategic plan for 2025 with the goals of making Flemingsberg the first choice for doing business in southern Stockholm, that Flemingsberg offers an internationally competitive innovation environment, and that Flemingsberg offers a testbed for societal challenges.
Don’t miss the opportunity to experience an interactive sound installation at the same time as you contribute to research that improves the future of urban planning.
Winner of the Flemingsberg Science Award IDEA this year was Hejfin. The innovation is an app for women and non-binary people to help them manage their personal finances.
Just south of Campus Flemingsberg, three life science companies - Bactiguard, Procella and Smartwise - share the same building. Their proximity to one another makes it possible to combine several different innovations in new forms of treatment.
Region Stockholm is now stepping up its efforts to become one of the world’s five leading centres for life science by 2025. Martin Tegnér leads the project from his newly setup programme office, which will oversee the initiative to completion.
In October, the Collaboration in Science conference attracted approximately 450 registered participants to Campus Flemingsberg to learn about research being conducted at Karolinska Institutet and Karolinska University Hospital.
The Flemingsberg Innovation Community is a meeting place that brings together a range of organisations that provide various types of innovation support and assistance. Among them is Sting, which since its inception in 2002, has guided hundreds of startup companies to success.
A Working Lab, (AWL), has now opened its doors in Flemingsberg. The site offers generous lab spaces in various sizes to help more businesses grow in a vibrant life science environment.
Uppsala-based Elicera Therapeutics is using the Pre-GMP core facility at Vecura in Flemingsberg as a first step in a study aimed at creating a new treatment for lymph node cancer.